鎮痛薬市場調査レポート：タイプ別（非オピオイドおよびオピオイド）、投与経路別（静脈内、経口、直腸、局所、および経皮）-2026年までの世界予測-COVID-19の累積的影響

世界の鎮痛薬の市場規模は、2020年の171億2367万米ドルから、2025年末までに248億8592万米ドルに成長すると予想されています。

COVID-19の累積的影響：

COVID-19は、ほぼすべての業界に影響を与えた比類のない世界的な公衆衛生上の緊急事態であるため、予測期間中に業界の成長に長期的な影響を与えると予測されます。私たちの進行中の調査は、調査フレームワークを増幅して、基礎となるCOVID-19の問題と今後の潜在的な道筋を確実に含めるようにしています。調査は消費者の行動と需要の変化、購入パターン、サプライチェーンの再ルーティング、現在の市場の力のダイナミクス、および政府の重要な介入を考慮したCOVID-19に関する洞察を提供しています。更新された調査は、市場へのCOVID-19の影響を考慮して、洞察、分析、推定、および予測を提供します。

レポートは次のような質問に答えます。

• 1.世界の鎮痛薬市場の市場規模と予測はどのくらいですか？
• 2.予測期間中に世界の鎮痛薬市場を形成するCOVID-19の阻害要因と影響は何ですか？
• 3.世界の鎮痛薬市場の予測期間中に投資する製品/セグメント/アプリケーション/領域はどれですか？
• 4.世界の鎮痛薬市場における機会の競争戦略ウィンドウは何ですか？
• 5.世界の鎮痛薬市場動向技術動向と規制の枠組みは何ですか？
• 6.世界の鎮痛薬市場に参入するのに適していると考えられるモードと戦略的動きは何ですか？

当レポートでは、鎮痛薬市場を調査し、市場概要、市場の成長要因および阻害要因の分析、タイプ別・地域別の市場規模の推移と予測、競合情勢、主要企業のプロファイル、市場機会など、包括的な情報を提供しています。

目次

第1章 序文

• 調査の目的
• 市場セグメンテーションとカバレッジ
• 調査対象年
• 通貨と価格
• 言語
• 制限事項
• 利害関係者

第2章 調査手法

• 調査プロセス
  • 定義：調査目的
  • 決定：調査デザイン
  • 準備：調査機器
  • 収集：データソース
  • 分析：データの解釈
  • 策定：データ検証
  • 公開：調査レポート
  • 繰り返し：レポートの更新
• 調査の実行
  • 開始：調査プロセス
  • 計画：調査計画を作成する
  • 実行：調査を実施する
  • 検証：発見と分析
  • 出版物：調査報告
• 調査成果

第3章 エグゼクティブサマリー

• イントロダクション
• 市場の見通し
• 投与経路の見通し
• タイプ別の見通し
• 地域別の見通し
• 競合他社の見通し

第4章 市場概要

• イントロダクション
• COVID-19の累積的影響

第5章 市場の洞察

• 市場力学
  • 促進要因
  • 抑制要因
  • 市場機会
  • 課題
• ポーターズファイブフォース分析
  • 新規参入業者の脅威
  • 代替品の脅威
  • 顧客の交渉力
  • 供給企業の交渉力
  • 業界の競争

第6章 タイプ別の世界の鎮痛薬市場

• イントロダクション
• 非オピオイド
• オピオイド

第7章 投与経路別の世界の鎮痛薬市場

• イントロダクション
• 静脈内
• オーラル
• 直腸
• 局所
• 経皮吸収

第8章 南北アメリカの鎮痛薬市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋鎮痛薬市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• 韓国
• タイ

第10章 欧州、中東・アフリカの鎮痛薬市場

• イントロダクション
• フランス
• ドイツ
• イタリア
• オランダ
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• アラブ首長国連邦
• 英国

第11章 競合情勢

• FPNVポジショニングマトリックス
  • 象限
  • 事業戦略
  • 製品の満足度
• 市場ランキング分析
• 市場シェア分析
• 競合他社のSWOT分析
• 競合シナリオ
  • 合併と買収
  • 合意、コラボレーション、およびパートナーシップ
  • 新製品の発売と強化
  • 投資と資金調達
  • 賞、表彰、拡大

第12章 企業のユーザビリティプロファイル

• Abbott Laboratories
• AbbVie Inc.
• Aspen Pharmacare Holdings Limited
• Astrazeneca PLC
• B. Braun Melsungen AG
• Baxter International Inc.
• Boehringer Ingelheim International GmbH
• Braun Melsungen AG
• Claris Life sciences
• Eisai Co. Ltd.
• F. Hoffmann-La Roche Ltd
• Fresenius SE & Co. KGaA
• Glenmark Pharmaceuticals Limited
• Hikma Pharmaceuticals PLC
• Hospira, Inc
• Maruishi Pharmaceutical Co., Ltd.
• Mylan NV
• Pacira Pharmaceuticals, Inc.
• Paion UK Ltd
• Pfizer Inc.
• Piramal Enterprises LTD
• Septodont
• Teva Pharmaceutical Industries Limited
• Troikaa Pharmaceuticals Ltd

第13章 付録

• ディスカッションガイド
• ライセンスと価格

LIST OF FIGURES

• FIGURE 1. GLOBAL ANALGESICS MARKET SIZE, 2020 VS 2026 (USD BILLION)
• FIGURE 2. GLOBAL ANALGESICS MARKET SIZE, BY DRUG TYPE, 2020 (USD BILLION)
• FIGURE 3. GLOBAL ANALGESICS MARKET SIZE, BY TYPE, 2020 (USD BILLION)
• FIGURE 4. GLOBAL ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 (USD BILLION)
• FIGURE 5. GLOBAL ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2020 (USD BILLION)
• FIGURE 6. GLOBAL ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2020 (USD BILLION)
• FIGURE 7. GLOBAL ANALGESICS MARKET: MARKET DYNAMICS
• FIGURE 8. GLOBAL ANALGESICS MARKET: PORTERS FIVE FORCES ANALYSIS
• FIGURE 9. GLOBAL ANALGESICS MARKET SIZE, BY DRUG TYPE, 2020 VS 2026 (%)
• FIGURE 10. GLOBAL ANALGESICS MARKET SIZE, BY DRUG TYPE, 2020 VS 2026 (USD BILLION)
• FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANALGESICS MARKET SIZE, BY DRUG TYPE, 2026
• FIGURE 12. GLOBAL ANALGESICS MARKET SIZE, BY ACETAMINOPHEN, 2018-2026 (USD BILLION)
• FIGURE 13. GLOBAL ANALGESICS MARKET SIZE, BY ACETAMINOPHEN, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
• FIGURE 14. GLOBAL ANALGESICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2026 (USD BILLION)
• FIGURE 15. GLOBAL ANALGESICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
• FIGURE 16. GLOBAL ANALGESICS MARKET SIZE, BY SALICYLATES, 2018-2026 (USD BILLION)
• FIGURE 17. GLOBAL ANALGESICS MARKET SIZE, BY SALICYLATES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
• FIGURE 18. GLOBAL ANALGESICS MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
• FIGURE 19. GLOBAL ANALGESICS MARKET SIZE, BY TYPE, 2020 VS 2026 (USD BILLION)
• FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANALGESICS MARKET SIZE, BY TYPE, 2026
• FIGURE 21. GLOBAL ANALGESICS MARKET SIZE, BY NON-OPIOIDS, 2018-2026 (USD BILLION)
• FIGURE 22. GLOBAL ANALGESICS MARKET SIZE, BY NON-OPIOIDS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
• FIGURE 23. GLOBAL ANALGESICS MARKET SIZE, BY OPIOIDS, 2018-2026 (USD BILLION)
• FIGURE 24. GLOBAL ANALGESICS MARKET SIZE, BY OPIOIDS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
• FIGURE 25. GLOBAL ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2026 (%)
• FIGURE 26. GLOBAL ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2026 (USD BILLION)
• FIGURE 27. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2026
• FIGURE 28. GLOBAL ANALGESICS MARKET SIZE, BY INTRAVENOUS, 2018-2026 (USD BILLION)
• FIGURE 29. GLOBAL ANALGESICS MARKET SIZE, BY INTRAVENOUS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
• FIGURE 30. GLOBAL ANALGESICS MARKET SIZE, BY ORAL, 2018-2026 (USD BILLION)
• FIGURE 31. GLOBAL ANALGESICS MARKET SIZE, BY ORAL, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
• FIGURE 32. GLOBAL ANALGESICS MARKET SIZE, BY RECTAL, 2018-2026 (USD BILLION)
• FIGURE 33. GLOBAL ANALGESICS MARKET SIZE, BY RECTAL, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
• FIGURE 34. GLOBAL ANALGESICS MARKET SIZE, BY TOPICAL, 2018-2026 (USD BILLION)
• FIGURE 35. GLOBAL ANALGESICS MARKET SIZE, BY TOPICAL, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
• FIGURE 36. GLOBAL ANALGESICS MARKET SIZE, BY TRANSDERMAL, 2018-2026 (USD BILLION)
• FIGURE 37. GLOBAL ANALGESICS MARKET SIZE, BY TRANSDERMAL, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
• FIGURE 38. GLOBAL ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2020 VS 2026 (%)
• FIGURE 39. GLOBAL ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2020 VS 2026 (USD BILLION)
• FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2026
• FIGURE 41. GLOBAL ANALGESICS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2026 (USD BILLION)
• FIGURE 42. GLOBAL ANALGESICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
• FIGURE 43. GLOBAL ANALGESICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2026 (USD BILLION)
• FIGURE 44. GLOBAL ANALGESICS MARKET SIZE, BY ONLINE PHARMACIES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
• FIGURE 45. GLOBAL ANALGESICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2026 (USD BILLION)
• FIGURE 46. GLOBAL ANALGESICS MARKET SIZE, BY RETAIL PHARMACIES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
• FIGURE 47. AMERICAS ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
• FIGURE 48. AMERICAS ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
• FIGURE 49. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2026
• FIGURE 50. ARGENTINA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
• FIGURE 51. BRAZIL ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
• FIGURE 52. CANADA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
• FIGURE 53. MEXICO ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
• FIGURE 54. UNITED STATES ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
• FIGURE 55. CALIFORNIA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
• FIGURE 56. FLORIDA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
• FIGURE 57. ILLINOIS ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
• FIGURE 58. NEW YORK ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
• FIGURE 59. OHIO ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
• FIGURE 60. PENNSYLVANIA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
• FIGURE 61. TEXAS ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
• FIGURE 62. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
• FIGURE 63. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
• FIGURE 64. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2026
• FIGURE 65. CHINA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
• FIGURE 66. INDIA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
• FIGURE 67. INDONESIA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
• FIGURE 68. JAPAN ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
• FIGURE 69. MALAYSIA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
• FIGURE 70. PHILIPPINES ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
• FIGURE 71. SOUTH KOREA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
• FIGURE 72. THAILAND ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
• FIGURE 73. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
• FIGURE 74. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
• FIGURE 75. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2026
• FIGURE 76. FRANCE ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
• FIGURE 77. GERMANY ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
• FIGURE 78. ITALY ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
• FIGURE 79. NETHERLANDS ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
• FIGURE 80. QATAR ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
• FIGURE 81. RUSSIA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
• FIGURE 82. SAUDI ARABIA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
• FIGURE 83. SOUTH AFRICA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
• FIGURE 84. SPAIN ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
• FIGURE 85. UNITED ARAB EMIRATES ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
• FIGURE 86. UNITED KINGDOM ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
• FIGURE 87. GLOBAL ANALGESICS MARKET: FPNV POSITIONING MATRIX
• FIGURE 88. GLOBAL ANALGESICS MARKET: SHARE, BY QUADRANT, 2020
• FIGURE 89. GLOBAL ANALGESICS MARKET: SHARE, BY COMPANY, 2020
• FIGURE 90. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ANALGESICS MARKET, BY TYPE

LIST OF TABLES

• TABLE 1. GLOBAL ANALGESICS MARKET: MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
• TABLE 3. GLOBAL ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 4. GLOBAL ANALGESICS MARKET SIZE, BY ACETAMINOPHEN, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 5. GLOBAL ANALGESICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 6. GLOBAL ANALGESICS MARKET SIZE, BY SALICYLATES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 7. GLOBAL ANALGESICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 8. GLOBAL ANALGESICS MARKET SIZE, BY NON-OPIOIDS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 9. GLOBAL ANALGESICS MARKET SIZE, BY OPIOIDS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 10. GLOBAL ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 11. GLOBAL ANALGESICS MARKET SIZE, BY INTRAVENOUS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 12. GLOBAL ANALGESICS MARKET SIZE, BY ORAL, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 13. GLOBAL ANALGESICS MARKET SIZE, BY RECTAL, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 14. GLOBAL ANALGESICS MARKET SIZE, BY TOPICAL, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 15. GLOBAL ANALGESICS MARKET SIZE, BY TRANSDERMAL, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 16. GLOBAL ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 17. GLOBAL ANALGESICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 18. GLOBAL ANALGESICS MARKET SIZE, BY ONLINE PHARMACIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 19. GLOBAL ANALGESICS MARKET SIZE, BY RETAIL PHARMACIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 20. AMERICAS ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 21. AMERICAS ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 22. AMERICAS ANALGESICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 23. AMERICAS ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 24. AMERICAS ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 25. ARGENTINA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 26. ARGENTINA ANALGESICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 27. ARGENTINA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 28. ARGENTINA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 29. BRAZIL ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 30. BRAZIL ANALGESICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 31. BRAZIL ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 32. BRAZIL ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 33. CANADA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 34. CANADA ANALGESICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 35. CANADA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 36. CANADA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 37. MEXICO ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 38. MEXICO ANALGESICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 39. MEXICO ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 40. MEXICO ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 41. UNITED STATES ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 42. UNITED STATES ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 43. UNITED STATES ANALGESICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 44. UNITED STATES ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 45. UNITED STATES ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 46. CALIFORNIA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 47. CALIFORNIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 48. CALIFORNIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 49. CALIFORNIA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 50. FLORIDA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 51. FLORIDA ANALGESICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 52. FLORIDA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 53. FLORIDA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 54. ILLINOIS ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 55. ILLINOIS ANALGESICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 56. ILLINOIS ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 57. ILLINOIS ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 58. NEW YORK ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 59. NEW YORK ANALGESICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 60. NEW YORK ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 61. NEW YORK ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 62. OHIO ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 63. OHIO ANALGESICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 64. OHIO ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 65. OHIO ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 66. PENNSYLVANIA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 67. PENNSYLVANIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 68. PENNSYLVANIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 69. PENNSYLVANIA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 70. TEXAS ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 71. TEXAS ANALGESICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 72. TEXAS ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 73. TEXAS ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 74. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 75. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 76. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 77. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 78. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 79. CHINA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 80. CHINA ANALGESICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 81. CHINA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 82. CHINA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 83. INDIA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 84. INDIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 85. INDIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 86. INDIA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 87. INDONESIA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 88. INDONESIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 89. INDONESIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 90. INDONESIA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 91. JAPAN ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 92. JAPAN ANALGESICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 93. JAPAN ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 94. JAPAN ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 95. MALAYSIA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 96. MALAYSIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 97. MALAYSIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 98. MALAYSIA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 99. PHILIPPINES ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 100. PHILIPPINES ANALGESICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 101. PHILIPPINES ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 102. PHILIPPINES ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 103. SOUTH KOREA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 104. SOUTH KOREA ANALGESICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 105. SOUTH KOREA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 106. SOUTH KOREA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 107. THAILAND ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 108. THAILAND ANALGESICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 109. THAILAND ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 110. THAILAND ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 111. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 112. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 113. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 114. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 115. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 116. FRANCE ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 117. FRANCE ANALGESICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 118. FRANCE ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 119. FRANCE ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 120. GERMANY ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 121. GERMANY ANALGESICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 122. GERMANY ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 123. GERMANY ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 124. ITALY ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 125. ITALY ANALGESICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 126. ITALY ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 127. ITALY ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 128. NETHERLANDS ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 129. NETHERLANDS ANALGESICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 130. NETHERLANDS ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 131. NETHERLANDS ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 132. QATAR ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 133. QATAR ANALGESICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 134. QATAR ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 135. QATAR ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 136. RUSSIA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 137. RUSSIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 138. RUSSIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 139. RUSSIA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 140. SAUDI ARABIA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 141. SAUDI ARABIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 142. SAUDI ARABIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 143. SAUDI ARABIA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 144. SOUTH AFRICA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 145. SOUTH AFRICA ANALGESICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 146. SOUTH AFRICA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 147. SOUTH AFRICA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 148. SPAIN ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 149. SPAIN ANALGESICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 150. SPAIN ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 151. SPAIN ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 152. UNITED ARAB EMIRATES ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 153. UNITED ARAB EMIRATES ANALGESICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 154. UNITED ARAB EMIRATES ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 155. UNITED ARAB EMIRATES ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 156. UNITED KINGDOM ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 157. UNITED KINGDOM ANALGESICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 158. UNITED KINGDOM ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 159. UNITED KINGDOM ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
• TABLE 160. GLOBAL ANALGESICS MARKET: SCORES
• TABLE 161. GLOBAL ANALGESICS MARKET: BUSINESS STRATEGY
• TABLE 162. GLOBAL ANALGESICS MARKET: PRODUCT SATISFACTION
• TABLE 163. GLOBAL ANALGESICS MARKET: RANKING
• TABLE 164. GLOBAL ANALGESICS MARKET: SHARE, BY QUADRANT, 2020
• TABLE 165. GLOBAL ANALGESICS MARKET: SHARE, BY COMPANY, 2020
• TABLE 166. GLOBAL ANALGESICS MARKET: MERGER & ACQUISITION
• TABLE 167. GLOBAL ANALGESICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
• TABLE 168. GLOBAL ANALGESICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
• TABLE 169. GLOBAL ANALGESICS MARKET: INVESTMENT & FUNDING
• TABLE 170. GLOBAL ANALGESICS MARKET: AWARD, RECOGNITION, & EXPANSION
• TABLE 171. GLOBAL ANALGESICS MARKET: LICENSE & PRICING
• TABLE 172. GLOBAL ANALGESICS MARKET: CONTACT DETAILS

The Global Analgesics Market size was estimated at USD 17.12 Billion in 2020 and expected to reach USD 18.53 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 8.60% to reach USD 28.09 Billion by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Analgesics to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Drug Type, the Analgesics Market was studied across Acetaminophen, Nonsteroidal Anti-inflammatory Drugs (NSAIDs), and Salicylates.

Based on Type, the Analgesics Market was studied across Non-opioids and Opioids.

Based on Route of Administration, the Analgesics Market was studied across Intravenous, Oral, Rectal, Topical, and Transdermal.

Based on Distribution, the Analgesics Market was studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.

Based on Geography, the Analgesics Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Analgesics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Analgesics Market, including 7T Pharma LLC, Abbott Laboratories, AbbVie Inc., Amphastar Pharmaceuticals, Inc., Aspen Pharmacare Holdings Limited, Astrazeneca PLC, Avir Pharma Inc, B. Braun Melsungen AG, Baxter International Inc., Boehringer Ingelheim International GmbH, Braun Melsungen AG, Cantrell Drug Company, Cipher Pharmaceuticals Inc., Cipla USA Inc., Claris Life sciences, Eisai Co. Ltd., Exelan Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd, Fresenius Kabi USA, LLC, Glenmark Pharmaceuticals Limited, Hikma Pharmaceuticals PLC, Hospira, Inc., Leucadia Pharmaceuticals, Maruishi Pharmaceutical Co., Ltd., Mylan Institutional LLC, Pacira Pharmaceuticals, Inc., Paion UK Ltd, Pfizer Inc., Piramal Enterprises LTD, Remedy Repack, Sandoz Inc, Septodont, Stat Rx USA, Teva Pharmaceutical Industries Limited, Troikaa Pharmaceuticals Ltd, Vertical Pharmaceuticals, Inc., and West-Ward Pharmaceuticals Corp.

The report provides insights on the following pointers:

• 1. Market Penetration: Provides comprehensive information on the market offered by the key players
• 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
• 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
• 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
• 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

• 1. What is the market size and forecast of the Global Analgesics Market?
• 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Analgesics Market during the forecast period?
• 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Analgesics Market?
• 4. What is the competitive strategic window for opportunities in the Global Analgesics Market?
• 5. What are the technology trends and regulatory frameworks in the Global Analgesics Market?
• 6. What is the market share of the leading vendors in the Global Analgesics Market?
• 7. What modes and strategic moves are considered suitable for entering the Global Analgesics Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

• 3.1. Introduction
• 3.2. Market Outlook
• 3.3. Drug Type Outlook
• 3.4. Type Outlook
• 3.5. Route of Administration Outlook
• 3.6. Distribution Outlook
• 3.7. Geography Outlook
• 3.8. Competitor Outlook

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidences of cardiovascular disease (CVD), cancer, & arthritis
    • 5.1.1.2. Frequent pain and aches encountered by the aging population
    • 5.1.1.3. Cost-efficiency of OTC analgesics drugs
  • 5.1.2. Restraints
    • 5.1.2.1. Uncontrolled prescriptions of opioids and drug abuse
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing investments in R&D by the public & private sectors
    • 5.1.3.2. Surge in popularity of personalized medicine
  • 5.1.4. Challenges
    • 5.1.4.1. Limited availability and affordability of high efficacy drugs, including opioid analgesics
• 5.2. Cumulative Impact of COVID-19
• 5.3. Porters Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry

6. Analgesics Market, by Drug Type

• 6.1. Introduction
• 6.2. Acetaminophen
• 6.3. Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
• 6.4. Salicylates

7. Analgesics Market, by Type

• 7.1. Introduction
• 7.2. Non-opioids
• 7.3. Opioids

8. Analgesics Market, by Route of Administration

• 8.1. Introduction
• 8.2. Intravenous
• 8.3. Oral
• 8.4. Rectal
• 8.5. Topical
• 8.6. Transdermal

9. Analgesics Market, by Distribution

• 9.1. Introduction
• 9.2. Hospital Pharmacies
• 9.3. Online Pharmacies
• 9.4. Retail Pharmacies

10. Americas Analgesics Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States
  • 10.6.1. California
  • 10.6.2. Florida
  • 10.6.3. Illinois
  • 10.6.4. New York
  • 10.6.5. Ohio
  • 10.6.6. Pennsylvania
  • 10.6.7. Texas

11. Asia-Pacific Analgesics Market

• 11.1. Introduction
• 11.2. China
• 11.3. India
• 11.4. Indonesia
• 11.5. Japan
• 11.6. Malaysia
• 11.7. Philippines
• 11.8. South Korea
• 11.9. Thailand

12. Europe, Middle East & Africa Analgesics Market

• 12.1. Introduction
• 12.2. France
• 12.3. Germany
• 12.4. Italy
• 12.5. Netherlands
• 12.6. Qatar
• 12.7. Russia
• 12.8. Saudi Arabia
• 12.9. South Africa
• 12.10. Spain
• 12.11. United Arab Emirates
• 12.12. United Kingdom

13. Competitive Landscape

• 13.1. FPNV Positioning Matrix
  • 13.1.1. Quadrants
  • 13.1.2. Business Strategy
  • 13.1.3. Product Satisfaction
• 13.2. Market Ranking Analysis
• 13.3. Market Share Analysis, By Quadrant
• 13.4. Market Share Analysis, By Company
• 13.5. Competitive Scenario
  • 13.5.1. Merger & Acquisition
  • 13.5.2. Agreement, Collaboration, & Partnership
  • 13.5.3. New Product Launch & Enhancement
  • 13.5.4. Investment & Funding
  • 13.5.5. Award, Recognition, & Expansion

14. Company Usability Profiles

• 14.1. 7T Pharma LLC
• 14.2. Abbott Laboratories
• 14.3. AbbVie Inc.
• 14.4. Amphastar Pharmaceuticals, Inc.
• 14.5. Aspen Pharmacare Holdings Limited
• 14.6. Astrazeneca PLC
• 14.7. Avir Pharma Inc
• 14.8. B. Braun Melsungen AG
• 14.9. Baxter International Inc.
• 14.10. Boehringer Ingelheim International GmbH
• 14.11. Braun Melsungen AG
• 14.12. Cantrell Drug Company
• 14.13. Cipher Pharmaceuticals Inc.
• 14.14. Cipla USA Inc.
• 14.15. Claris Life sciences
• 14.16. Eisai Co. Ltd.
• 14.17. Exelan Pharmaceuticals, Inc.
• 14.18. F. Hoffmann-La Roche Ltd
• 14.19. Fresenius Kabi USA, LLC
• 14.20. Glenmark Pharmaceuticals Limited
• 14.21. Hikma Pharmaceuticals PLC
• 14.22. Hospira, Inc.
• 14.23. Leucadia Pharmaceuticals
• 14.24. Maruishi Pharmaceutical Co., Ltd.
• 14.25. Mylan Institutional LLC
• 14.26. Pacira Pharmaceuticals, Inc.
• 14.27. Paion UK Ltd
• 14.28. Pfizer Inc.
• 14.29. Piramal Enterprises LTD
• 14.30. Remedy Repack
• 14.31. Sandoz Inc
• 14.32. Septodont
• 14.33. Stat Rx USA
• 14.34. Teva Pharmaceutical Industries Limited
• 14.35. Troikaa Pharmaceuticals Ltd
• 14.36. Vertical Pharmaceuticals, Inc.
• 14.37. West-Ward Pharmaceuticals Corp

15. Appendix

• 15.1. Discussion Guide
• 15.2. License & Pricing
• 15.3. Contact Details